{"id":15597,"date":"2023-05-12T09:51:00","date_gmt":"2023-05-12T09:51:00","guid":{"rendered":"http:\/\/model1.caplinpoint.net\/?p=15597"},"modified":"2023-12-09T09:54:53","modified_gmt":"2023-12-09T09:54:53","slug":"caplin-steriles-gets-usfda-approval-for-ketorolac-tromethamine-injection","status":"publish","type":"post","link":"http:\/\/model1.caplinpoint.net\/index.php\/2023\/05\/12\/caplin-steriles-gets-usfda-approval-for-ketorolac-tromethamine-injection\/","title":{"rendered":"CAPLIN STERILES GETS USFDA APPROVAL FOR KETOROLAC TROMETHAMINE INJECTION"},"content":{"rendered":"\n<p>Chennai, May 12, 2023: Caplin Steriles Limited (Caplin), a Subsidiary Company of Caplin Point Laboratories Limited (BSE: CAPPL (524742), NSE: CAPLIPOINT), has been granted final approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Ketorolac Tromethamine Injection USP, 15 mg\/mL and 30 mg\/mL Single-dose Vial, a generic therapeutic equivalent version of (RLD), TORADOL injection of Roche.<\/p>\n\n\n\n<p>Ketorolac Tromethamine Injection USP is a nonsteroidal anti-inflammatory drug (NSAID), indicated for the short-term (\u22645 days) management of moderately severe acute pain. According to IQVIATM (IMS Health), Ketorolac Tromethamine Injection USP had US sales of approximately $53 million for the 12-month period ending December 2022.<\/p>\n\n\n\n<p>Mr. C. C. Paarthipan, Chairman of Caplin Point Laboratories Limited commented <em>&#8220;Our regulated markets business continues to grow at a robust pace, and this new approval will help augment the growth. We have also received a few approvals from other markets such as Canada and Australia and we look forward to launches there within this year too.&#8221;<\/em><\/p>\n\n\n\n<div class=\"wp-block-file\"><a target=\"_blank\" href=\"http:\/\/model1.caplinpoint.net\/wp-content\/uploads\/2023\/04\/PressReleaseCSLfinal.pdf\" class=\"wp-block-file__button\" rel=\"noopener\">Download<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Chennai, May 12, 2023: Caplin Steriles Limited (Caplin), a Subsidiary Company of Caplin Point Laboratories Limited (BSE: CAPPL (524742), NSE: CAPLIPOINT), has been granted final approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Ketorolac Tromethamine Injection USP, 15 mg\/mL and 30 mg\/mL Single-dose Vial, a generic&#8230; <\/p>\n","protected":false},"author":1,"featured_media":1229,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":[],"categories":[1],"tags":[],"_links":{"self":[{"href":"http:\/\/model1.caplinpoint.net\/index.php\/wp-json\/wp\/v2\/posts\/15597"}],"collection":[{"href":"http:\/\/model1.caplinpoint.net\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/model1.caplinpoint.net\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/model1.caplinpoint.net\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/model1.caplinpoint.net\/index.php\/wp-json\/wp\/v2\/comments?post=15597"}],"version-history":[{"count":1,"href":"http:\/\/model1.caplinpoint.net\/index.php\/wp-json\/wp\/v2\/posts\/15597\/revisions"}],"predecessor-version":[{"id":15598,"href":"http:\/\/model1.caplinpoint.net\/index.php\/wp-json\/wp\/v2\/posts\/15597\/revisions\/15598"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/model1.caplinpoint.net\/index.php\/wp-json\/wp\/v2\/media\/1229"}],"wp:attachment":[{"href":"http:\/\/model1.caplinpoint.net\/index.php\/wp-json\/wp\/v2\/media?parent=15597"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/model1.caplinpoint.net\/index.php\/wp-json\/wp\/v2\/categories?post=15597"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/model1.caplinpoint.net\/index.php\/wp-json\/wp\/v2\/tags?post=15597"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}